Age
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs SHHS Visit Number
Visit 1 | Visit 2 | CVD Outcomes | |
---|---|---|---|
Total | 5,804 | 4,080 | 5,042 |
No | 5,653 | - | - |
Yes | 133 | - | - |
Unknown | 18 | 4,080 | 5,042 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Age at SHHS1
Visit 1
39.0 to 55.0 years | 55.0 to 63.0 years | 63.0 to 72.0 years | 72.0 to 100.0 years | Total | |
---|---|---|---|---|---|
Total | 1,451 | 1,451 | 1,451 | 1,451 | 5,804 |
No | 1,434 | 1,439 | 1,408 | 1,372 | 5,653 |
Yes | 7 | 9 | 43 | 74 | 133 |
Unknown | 10 | 3 | - | 5 | 18 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 1
Female | Male | Total | |
---|---|---|---|
Total | 3,039 | 2,765 | 5,804 |
No | 2,984 | 2,669 | 5,653 |
Yes | 48 | 85 | 133 |
Unknown | 7 | 11 | 18 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 2
Female | Male | Total | |
---|---|---|---|
Total | 2,219 | 1,861 | 4,080 |
No | - | - | - |
Yes | - | - | - |
Unknown | 2,219 | 1,861 | 4,080 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 1
white | black | native amer/alaskan | asian/pacific islander | hispanic/mex. amer | other | Total | |
---|---|---|---|---|---|---|---|
Total | 4,907 | 515 | 11 | 88 | 280 | 3 | 5,804 |
No | 4,776 | 503 | 10 | 85 | 276 | 3 | 5,653 |
Yes | 121 | 7 | 1 | 2 | 2 | - | 133 |
Unknown | 10 | 5 | - | 1 | 2 | - | 18 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 2
white | black | native amer/alaskan | asian/pacific islander | hispanic/mex. amer | other | Total | |
---|---|---|---|---|---|---|---|
Total | 3,587 | 256 | 8 | 48 | 180 | 1 | 4,080 |
No | - | - | - | - | - | - | - |
Yes | - | - | - | - | - | - | - |
Unknown | 3,587 | 256 | 8 | 48 | 180 | 1 | 4,080 |